Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced ...

BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...

The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...

The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), is expanding its BFS ...

"Woodstock Sterile Solutions invests in new bottle packaging line" was originally created and published by Packaging Gateway, ...

“In clinical drug development, time is everything. Delays in sterile fill/finish can mean missed trial milestones and significant financial setbacks,” said Colleen Dixon, CEO of Selkirk Pharma.

"The refinancing demonstrates the confidence our lenders and investors have in Curia,” said Philip Macnabb, Chief Executive Officer. “The new credit facility will enable us to continue investing in ...

New High-Speed Filling Line to Support Growing Demand for Sterile Injectables and Strengthen Domestic Supply Chain- -Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT ...

Container filling can be performed via peristaltic pump or vacuum. Additional syringe, cartridge, and vial options will be introduced based on demand. Meeting Industry Needs for Sterile Injectable ...